Test Order

Test Order
Print
Related Pages

NARMS Susceptibility Testing CDC-10107

Synonym(s)
National Antimicrobial Resistance Monitoring System, NARMS surveillance, AST
CDC Pre-Approval Needed
None
Supplemental Information Required
Submitter must be a NARMS participating laboratory. Specimens accepted according to current National Antimicrobial Resistance Monitoring System (NARMS) sampling scheme. NARMS log sheet or entry into NARMS web interface.
Supplemental Form
Performed on Specimens from
Human
Acceptable Sample/ Specimen Type for Testing
Isolates. Specimens accepted according to NARMS guidelines.
Minimum Volume Required
Minimum volume for microbrial isolates is not applicable
Collection, Storage, and Preservation of Specimen Prior to Shipping
Store isolates at ambient temperature (15-25 °C) or refrigerate (2-8 °C). Isolates held for more than a month should be frozen at less than or equal to -20 °C.
Transport Medium
Ship isolates on nutrient agar or non-selective similar agar (trypticase soy agar, heart infusion agar, etc.)
Specimen Labeling
Research or surveillance specimens may be labeled according to protocol. Labels should not include personally identifiable information. The results reported should NOT be used for diagnosis, treatment, assessment of health or management of the individual patient.
Shipping Instructions which Include Specimen Handling Requirements
Ship at ambient temperature or frozen with dry ice. There are no time contraints for submitting sequence data.
 
CDC does not accept routine shipments on weekends or holidays.  Please make sure packages arrive Monday - Friday.
 
Ship to:
<Insert CDC Point of Contact>
Centers for Disease Control and Prevention
RDSB/STATT Unit 127
1600 Clifton Road, NE
Atlanta, GA 30329
<Insert CDC Point of Contact's Telephone Number>
 
All samples must be shipped in accordance with all applicable local, state and federal regulations.
Methodology
Broth Microdilution Antimicrobial Susceptibility (AST), E-Test Susceptibility Testing
Turnaround Time
8 Weeks
Interferences & Limitations
No significant interferences or limitations are currently known.
Additional Information
The turn around time depends on the nature of subtyping performed. Results are typically reported directly to the surveillance databases. For additional information regarding shipment timing and other status updates, please see this link: https://wwwn.cdc.gov/NARMS/UserLogin.aspx
CDC Points of Contact
Jean Whichard
(404) 639-2000
zyr3@cdc.gov
Jason Folster
(404) 639-4948
gux8@cdc.gov
Hayat Caidi
(404) 639-0766
foi0@cdc.gov


Version
1.3